YZYao Zhang

Yao Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yao Zhang has a total of 127 co-authors. Here are the top co-authors by number of shared publications:

  • Ping Xu

    State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China

    16 shared publications
  • Lei Chang

    Research Unit of Proteomics & Research and Development of New Drug (Chinese Academy of Medical Sciences), Beijing Life Science Academy, National Center for Protein Sciences (Beijing), Academy of Military Medical Sciences

    15 shared publications
  • Songhao Jiang

    Research Unit of Proteomics & Research and Development of New Drug (Chinese Academy of Medical Sciences), Beijing Life Science Academy, National Center for Protein Sciences (Beijing), Academy of Military Medical Sciences

    10 shared publications
  • Jiahui Shi

    Academy of Military Medical Sciences

    8 shared publications
  • Tao Zhang

    Academy of Military Medical Sciences

    6 shared publications
  • Wenhui Wu

    State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing 102206, China

    6 shared publications

Latest Publications

  • Digitonin-Based Permeabilization Enables Rapid Enrichment of Membrane Proteins for Deep Proteomics

    by Yao Zhang, Jiahao Wang, Hui Liu, Jilin Dong, Jialin Liu, Songhao Jiang, Zhi Li, Yuan Ma, Qinna Ying, Han Yang, et al.

    Membrane proteins (MPs) govern molecular transport, signal transduction, and intercellular communication and are central to mechanistic biology, biomarker discovery, and therapeutic targeting. Their hydrophobicity, low abundance, and poor solubility, however, continue to complicate efficient recovery and deep proteomic analysis. Here, we developed a digitonin-mediated permeabilization workflow for rapid MPs enrichment and systematically optimized digitonin concentration, incubation temperature, and treatment duration. Under the optimized condition (0.01% digitonin at 37 °C for 30 min), soluble cytosolic proteins were efficiently released while membrane-associated material was retained for subsequent detergent extraction. Across two independent THP-1 membrane-proteomics experiments, approximately 75−78% of proteins that were more abundant in the digitonin-enriched fraction than in total cell lysate were annotated as MPs. The workflow reduces sample handling and can be completed in approximately 2 h. Marker-based validation in HeLa cells, primary human PBMCs, and pathogen-infected THP-1 macrophages further supported effective cytosolic release and membrane retention in additional cellular contexts. Together, these results establish digitonin permeabilization as a simple and practical front-end strategy for membrane proteomics, while its performance in additional primary and disease-derived specimens remains to be defined.

  • Integrative Proteomics and Ubiquitomics Reveal on-Targets and off-Targets of PROTAC dBET1

    by Hongtao Wen, Hui Liu, Jinfang Liu, Bendong Yang, Jiaxing Dai, Lei Chang, Yanchang Li, Yao Zhang, Liyan Yu, Ping Xu

    Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules that induce selective degradation of target proteins by hijacking the ubiquitin-proteasome system (UPS). Despite their transformative potential in eliminating disease-associated proteins, comprehensively identifying off-target degradation events remains technically challenging. Here, we employed an integrated proteomic and ubiquitinomic strategy to systematically profile the degradation landscape of the PROTAC molecule dBET1 in Jurkat T cells. By capturing the upstream ubiquitination events─which serve as earlier and more sensitive indicators than total protein abundance─our approach enabled the identification of previously overlooked off-target candidates. While dBET1 efficiently degraded its canonical BET family targets, our data also revealed the mitochondrial outer membrane protein VDAC1 as a putative off-target, evidenced by its depletion and increased multisite ubiquitination. Notably, our analysis framework enabled site-specific resolution of degradation events within BRD3, revealing preferential ubiquitination at functionally essential bromodomains, suggesting that degron-enriched regions may underlie domain-selective degradation. Additionally, dBET1 treatment was associated with mitochondrial depolarization and calcium homeostasis disruption, defects that we hypothesize may be functionally linked to the observed VDAC1 depletion. Together, this study demonstrates that integrating ubiquitomics provides a superior sensitivity layer for PROTAC safety assessment, capable of uncovering mechanism-based liabilities that escape conventional global proteomic screening.

  • A Robust, Self-Digestion-Resistant LysN with Superior Activity and Cleavage Fidelity for Advanced Proteomic Workflows

    by Jiaxing Dai, Jiahui Shi, Tao Zhang, Lei Chang, Yao Zhang, Yuping Xie, Bin Fu, Zhitang Lyu, Ping Xu

    LysN is a valuable protease in proteomics because it cleaves peptide bonds N-terminal to lysine, generating peptides with physicochemical properties complementary to those produced by LysC and trypsin. However, the broader adoption of LysN in proteomic workflows has been limited by the lack of commercially available enzymes that combine high activity, low missed-cleavage rates, and sufficient stability under practical sample-processing conditions. Here, we report the recombinant production and proteomic characterization of a self-digestion-resistant and highly active LysN from Shewanella loihica (SL-LysN). Using terminomics, we mapped the mature N- and C-termini of the enzyme and established the primary structure of the active protease. We further developed a high-density fermentation, refolding, and purification workflow to obtain highly purified recombinant SL-LysN. Biochemical and proteomic benchmarking showed that SL-LysN displayed 3.3-fold higher specific activity than commercial LysN and reduced missed cleavages by approximately 80%. Notably, SL-LysN retained high activity in the presence of 8 M urea or 1% SDS and showed strong resistance to autolysis, indicating exceptional robustness for proteomic sample preparation. In complex mammalian proteome digests, SL-LysN achieved >95% cleavage specificity and a missed-cleavage rate of only 5.9%. These features address a long-standing bottleneck in N-terminal proteolysis and establish SL-LysN as a high-performance enzymatic tool for advanced proteomic workflows, including deep protein sequencing, quantitative proteomics, terminomics, de novo sequencing and analyses requiring efficient digestion under denaturing conditions.

  • Open Access

    DiNovo enables high-coverage and high-confidence de novo peptide sequencing via mirror proteases and deep learning

    by Zixuan Cao, Xueli Peng, Di Zhang, Piyu Zhou, Li Kang, Hao Chi, Ruitao Wu, Zhiyuan Cheng, Yao Zhang, Jiaxing Dai, et al.

    Despite the recent advancements driven by deep learning, de novo peptide sequencing is still constrained by incomplete peptide fragmentation and insufficient protein digestion in current single protease-based proteomic experiments. Here, we present a software system, named DiNovo, for high-coverage and high-confidence de novo peptide sequencing by leveraging the complementarity of mirror proteases. DiNovo is empowered by several innovative algorithms, including a mirror-spectra recognition algorithm independent of pre-sequencing, two sequencing algorithms based on deep learning and graph theory, respectively, and target-decoy mapping, a method for sequencing result evaluation free of prior peptide identification. Compared with the trypsin protease used alone, DiNovo using two pairs of mirror proteases leads to two to three times high-confidence amino acids sequenced. Compared with previous single-protease de novo sequencing algorithms, DiNovo achieves much higher sequence coverage. DiNovo also shows great potential as a practical and powerful alternative to database search for peptide identification with quality control.


  • Plasma exosomes reveal insights into bovine tuberculosis pathogenesis and diagnostic opportunities

    by Hangfan Zhou, Qilong Zhang, Songhao Jiang, Han Yang, Shujie Cui, Wenhui Wu, Lei Chang, Wanjun Zhang, Yuping Xie, Jiaqiang Zhu, et al.

  • Exosomal Proteome from Hepatocellular Carcinoma Patient-Derived Xenograft Mice Serves as Identity of Liver Cancer

    by Tao Zuo, Peiru Chen, Zhenpeng Zhang, Mingsong Mao, Yuan Li, Zilin Li, Xin Feng, Yihao Wang, Zhen Sun, Fenglong Jiao, et al.

    Hepatocellular carcinoma (HCC) constitutes approximately 90% of liver cancers, yet its early detection remains challenging due to the low sensitivity of current diagnostic methods and the difficulty in identifying minimal cancer cells within the body. This study employed a patient-derived xenograft (PDX) mouse model to screen for biomarkers, leveraging its advantage of low background interference compared to human serum exosome studies. Using a novel microextraction technique, exosomes were isolated from just one microliter of serum from HCC PDX mice, followed by proteomic profiling. Analysis revealed that serum exosomal proteins from PDX mice were enriched in cancer-related pathways. The exosomal proteome not only distinguished PDX mice from controls but also differentiated between individual PDX groups, supporting its use as a tumor-specific identifier (tumor ID) and a noninvasive tool for monitoring tumors. Bioinformatics identified a panel of serum exosomal protein biomarkers predictive of HCC patient outcomes, which were validated via targeted proteomics and array-based high-throughput detection. These upregulated biomarkers in HCC patients positively correlate with disease severity and poor prognosis, underscoring their clinical potential.


  • Open Access

    Serum-derived exosome proteomics unveils the distinct and adjustable nature of the dampness constitution in traditional Chinese medicine

    by Wenhui Wu, Chengcheng Wang, Tao Zhang, Xinyan Chen, Hangfan Zhou, Fei Tan, Jiamin Yuan, Lei Chang, Chen Sun, Yi Sun, et al.


  • Quantitative Proteome Analysis of Plasma Extracellular Vesicles Identifies Three Proteins with Potential Diagnostic Value for Mycobacterium bovis Infection in Cows

    by Hangfan Zhou, Wenhui Wu, Qilong Zhang, Tao Zhang, Songhao Jiang, Hui Liu, Yuan Ma, Lei Chang, Yuping Xie, Jiaqiang Zhu, et al.

    Bovine tuberculosis (bTB) is a zoonotic disease that affects cattle and human health. Although the tuberculin skin test (TST) is the main detection method, there is a need for simpler on-farm tests using fluid samples. This study analyzed plasma extracellular vesicles (EVs) from two cow groups (Cohort A, 15 negative, 22 positive; Cohort B, 28 negative, 40 positive) to explore bTB indicators using proteome profiling. Among the 756 proteins, 217 (Cohort A) and 233 (Cohort B) showed differences between healthy and infected cows, with 47 consistently dysregulated in both groups. These proteins were related to tuberculosis, neutrophil extracellular trap formation, and antigen processing and presentation pathways. Notably, three proteins, HSPA8, B2M, and HRG, were confirmed as bTB indicators using multiple methods, including least absolute shrinkage and selection operator (Lasso) regression selection, western blot (WB), and enzyme-linked immunosorbent assay (ELISA) validation with an independent cohort (Cohort C). This study identifies plasma EV biomarkers for bTB infection, offering insights for bTB detection.


  • Phosphoproteomics delineates hepatocellular carcinoma subtypes and pinpoints therapeutic targets

    by Ze Zhang, Zhenpeng Zhang, Yao Zhang, Yuan Li, Kaixuan Li, Shu Liu, Junning Cao, Yanchang Li, Xuehui Peng, Suzhen Li, et al.

    Background & Aims: Only a minority of patients could benefit from systemic therapy owing to the high heterogeneity of HCC. Therefore, a deeper understanding of the pathogenesis of HCC is essential for precision therapy. Genomic and proteomic studies of HCC have enhanced our understanding of HCC. However, phosphoproteomic characterization of HCC remains poorly understood. Approach & Results: We conducted an in-depth analysis of a clinical cohort of HCC using high-coverage phosphoproteomic. Effective therapeutic targets were validated using liver cancer cell lines and HCC patient-derived xenograft (PDX) mouse models that correspond to the phosphoproteomic subtypes of HCC. Phosphoproteomic analysis classified HCC into three subtypes, A, B, and C, with increasing malignancy and correlation with clinical features, including patient prognosis, tumor staging, serum alpha fetoprotein (AFP) levels, tumor thrombus, and tumor size. Phosphoproteomic subtyping deeply reflected the biological characteristics and clinical features of HCC patients. The profiles of HCC dysregulated kinase activities inferred from the different phosphoproteomic subtypes, consistently identifying increased kinase activity related to cell proliferation. Subtype-C HCC patients showed the most significant dysregulation, indicating a potential therapeutic target. The corresponding drug, bosutinib, demonstrated efficacy in inhibiting the growth of subtype C tumors in liver cancer cell lines and HCC patient-derived xenograft (PDX) mouse models representative of the phosphoproteomic HCC subtypes. Conclusions: Our study provides a comprehensive exploration of the phosphoproteomic landscape of HCC, establishing new subtypes that match clinical features and identifying potential therapeutic targets for the most malignant C subtype. Export


  • Shotgun and targeted proteomics of Mycolicibacterium smegmatis highlight the role of arginine phosphorylation in the functional adaptation to its environment

    by Danyang Xu, Jiahui Shi, Songhao Jiang, Shuhong Meng, Zhiyuan Cheng, Wenhui Wu, Lei Chang, Yuping Xie, Yuan Gao, Yu Xue, et al.